Skip to main content
  • EMEA
  • MedTech

Article 16(4) MDR & IVDR Certification: What Medical Device Manufacturers Need to Know

Medical device importers, distributors and others who modify medical devices for sale in the European Union should understand new requirements set by Article 16(4) of the European Union MDR and IVDR certification schemes.

  • North America
  • MedTech

US FDA Warning Letters: Considerations for LDTs including Timelines

Reviewing relevant U.S. Food and Drug Administration (FDA) warning letters can help manufacturers better understand areas of frequent concern related to quality management systems (QMS) and regulatory affairs. This allows companies to focus on areas of highest risk.

CMEF 2025

Schedule a meeting to learn more about how we can support you in getting to market faster.

EU AIA and its Interplay with the EU MDR/IVDR

Know how the EU Artificial Intelligence Act redefines the regulatory environment for AI-driven medical devices and IVDs.

Understanding Japan’s Clinical Data Requirements

The PMDA determines if clinical data is required for a medical device premarket authorization in Japan depending on the manufacturer’s non-clinical data and equivalence with like devices.

  • North America
  • MedTech

Health Canada Continues to Actively Monitor Supply of Medical Devices

The Canadian medical device regulator Health Canada continues to add and remove devices deemed in short supply.

  • Global
  • MedTech

IMDRF Updates Terminologies for Categorized Adverse Event Reporting

The technical document that defines the categories for adverse event reporting for medical devices has been updated by the IMDRF.

  • EMEA
  • MedTech

MHRA Publishes the Consultation Outcome on Statutory Fees

From August 29, 2024, to October 24, 2024, the Medicines & Healthcare products Regulatory Agency (MHRA) held a public consultation on its proposed amendments to the statutory fees. The consultation reflected fees for services related to medicines, medical devices and blood components for transfusion in the UK

QMS Audit Readiness

In this on-demand webinar, our Emergo by UL subject matter expert shares insights on how to navigate QMS audits, including FDA, MDSAP and ISO.

Japan Regulatory Requirements – PMDA Pre-submission Consultation Program

In this webinar, our Emergo by UL expert outlines the latest updates on regulatory requirements in Japan.